Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Country / region: Russia Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20052
20082
20092
20101
20111
20133
20151
20161
20173
20185
20195
20212
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Active, not recruiting4
Terminated4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer7
AstraZeneca4
Bristol-Myers Squibb3
Hoffmann-La Roche3
Merck Sharp & Dohme LLC2
Abbott1
Eisai Co., Ltd.1
Eisai Inc.1
Eisai Limited1
Exelixis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular32
Liver Neoplasms10
Neoplasms5
Carcinoma2
Adenocarcinoma1
Biliary Fistula1
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Transitional Cell1
Colorectal Neoplasms1

Trials

Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.